Ulcerative colitis trials in Bosnia & Herzegovina

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  Where

  Banja Luka, Mostar, Sarajevo

  Age

  18 years to 75 years

  People

  645 worldwide

  Run by

  Spyre Therapeutics, Inc.

  See details and how to joinNCT07012395 · EU 2025-521242-26-00